Conceivable Life Sciences’ Post

Congratulations team! Exciting Technological Breakthrough! For over a decade, CTC isolation technology has seen minimal advancements. Thanks to a multi-departmental collaborative effort spanning engineering, chemistry, and medicine, we've developed a cutting-edge portable device capable of sensitively trapping & analysing CTCs. This brings us one step closer to enabling bedside/in-clinic CTC analysis for rapid decision-making. Macquarie University; University of Melbourne; Austin Health #HealthcareInnovation, #CancerTreatment, #CancerResearch, #Innovation, #HealthTech, #MedicalScience, #ResearchDiscoveries, #BreastCancer, #TumorMarker, #MedicalDevice, #Oncology

New scientific publication! 📢 We are thrilled to announce that the results of a new clinical trial have been published in Frontiers 🎉 This multicentric study investigated the feasibility and usability of the ABLE Exoskeleton (clinical use device) for individuals with spinal cord injury to perform skills for home and community environments. The results and feedback gathered have been crucial for the development of our novel personal-use exoskeleton that we aim to launch in 2 years. Stay tuned! 🚀 The supervised use in the clinical environment has been a highly valuable approach for identifying the challenging tasks and the necessary technological developments needed for a personal-use exoskeleton 🏡 : ✅ A more independent sit-to-stand ✅ Faster speed of transitions between states ✅ A richer display on the remote control for the user ✅ Higher walking speed to improve access to community environments This study was conducted in two prestigious European #SCI centres: Institut Guttmann and University Hospital Heidelberg, and funded by EIT Health. We are deeply grateful for your ongoing support and collaboration! A huge thank you to all the authors for the great work and efforts put into this project, without you ABLE would not be what it is today. It has been a tremendous pleasure to collaborate with you the last few years and we hope to continue collaborating in the near future! 👨⚕️👩⚕️Mark Wright, Eloy Opisso, Helena Lopez Matas, Erika Porras Martínez, Alfons Carnicero Carmona, Cornelia Hensel, Franziska Nadorf, Steffen Franz, Norbert Weidner, Joan Vidal & Rüdiger Rupp Read the full article here! 👉 https://lnkd.in/dkKVG8rF Curious about all the scientific publications on the ABLE Exoskeleton? Learn about them here 👉 https://lnkd.in/db3PfmcP   #ClinicalResearch #ClinicalTrial #User-centered #MedicalTechnology #ABLEHumanMotion #ExoskeletonTechnology #SpinalCordInjury #Neuro #Rehabilitation #Innovation #MobilityForAll #FrontiersInScience

🌟 Empowering Lives Through Innovation in EBME 🌟 This week, we reflect on how every breakthrough in Electro Biomedical Engineering (EBME) not only advances technology but fundamentally enhances health and quality of life. Our quote of the week encapsulates this perfectly: "In EBME, every innovation is a step towards empowering individuals, enhancing both health and quality of life." From developing more intuitive prosthetics to creating smarter monitoring systems, each innovation in EBME is a testament to the power of technology to transform lives. Let's celebrate the incredible progress in this field and continue to support the innovations that bring hope and improved functionality to individuals around the world. What recent innovation in EBME has inspired you? Share your thoughts and join the conversation on how technology is making a real difference in healthcare. #EBME #HealthcareInnovation #BiomedicalEngineering #TechForGood #InnovationInHealthcare #EmpoweringLives #QualityOfLife #nGenium Sam O'Leary Nathan Upton Nathan Read Alan Ling Jowell Grandison

Muscle "weakness" is commonly assessed using techniques that fail to identify if that weakness is the result of a reduced force-generating ability, impaired (neural) access to that ability, or both. Knowing which can mean the difference between prescribing effective interventions versus not. Did you know that people post-stroke often have residual force-generating ability that they can't access voluntarily? Did you know that the magnitude of this latent force-generating ability is associated with persisting gait impairments in the chronic phase of recovery? And did you know that similar deficits in plantarflexor central drive are present with age-related neuromuscular decline and other neurological conditions? Knowing isn't enough!! Clinicians need to be able to measure the problem to treat the problem. In collaboration with Conor Walsh's Biodesign Lab, we are advancing new point-of-care diagnostic technologies that can fill this clinical measurement gap. Check out Dave Sherman's great summary of our recent paper in Bioengineering MDPI presenting the CEntral DRive System (CEDRS) - a project co-led by Ashley Collimore, PhD from Boston University Sargent College's Neuromotor Recovery Lab and Jonathan Alvarez from Harvard John A. Paulson School of Engineering and Applied Sciences's Biodesign Lab. https://lnkd.in/edHxejq6

🎉 Exciting news from Assistive Technology Development! They have been awarded $306,872 by the U.S. Department of Health and Human Services (HHS), specifically the National Institutes of Health and the NIH National Institute of Biomedical Imaging and Bioengineering. This funding will support the development of a lightweight robotic telerehabilitation device with integrated blood flow restriction for patients with musculoskeletal conditions. This innovative device aims to reduce recovery costs and improve outcomes for patients undergoing knee surgeries by providing motorized exercise modes and data sharing capabilities. #SBIR #STTR #Innovation 💡 The project will focus on creating a cost-effective device that enhances low-load exercise benefits while reducing clinic visits and supporting patients in rural areas. The research will include pilot usability studies with physical therapists and patients recovering from ligament reconstruction. The award, classified as a project grant, will last for 12 months, starting on September 1, 2024, and ending on August 31, 2025. We can't wait to see the positive impact this technology will have on the healthcare industry! #HealthcareInnovation #Rehabilitation #TechForGood

🌟Harnessing the power of scientific collaboration to drive life-changing innovations for the CF community! 🌟 We are thrilled to announce that we’ve awarded $859,932 in our ✨first ever ✨Collaborative Research Grant to researchers at University of Iowa Roy J. and Lucille A. Carver College of Medicine, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, and University of Rochester School of Medicine and Dentistry to support their important work focused on improving how CF therapeutics are delivered effectively to airway cells. Led by Paul McCray, MD, Beverly Davison, PhD, and John Lueck, PhD, this groundbreaking project will use advanced AAV capsid variants to develop targeted therapies for people with #CysticFibrosis. We are incredibly proud to support this cutting-edge research that holds the potential to provide curative treatments for all people with CF, including those in the final 10% who do not benefit from current therapies. Learn more: https://bit.ly/3KlYdlq #CureCF #RearchGrants #CysticFibrosisResearch #CFresearch

Solicitation for Neuromedical Innovation Funding is now open! NeuroTech Harbor (NTH) is the Nation’s first Equitech ecosystem for neuromedical solutions. NTH is a partnership between Johns Hopkins University and Howard University funded by the NIH with plans to spend between $30-$50 million to launch 45 new neurological health innovation projects over the next 5 years. The Equitech approach supports inclusive medical technologies that are designed and developed to meet the diverse needs of all individuals, regardless of their abilities, disabilities, or cultural backgrounds in an effort to promote equity, accessibility, and inclusivity in healthcare. Apply for Cycle 4 Funding here: https://lnkd.in/e8b8U8Ax

👁 PRESS RELEASE Realheart to Present Positive Results From Two Preclinical Studies Evaluating Treatment Safety of Its Total Artificial Heart at ISMCS - International Society for Mechanical Circulatory Support 2024. 👉🏿 As part of the preclinical development program of Realheart® TAH, the company has evaluated the mechanical stress effects of its total artificial heart on human blood, as well as its capability to respond adequately to varying blood flow demands in the cardiovascular system. In the current studies, the performance of Realheart® TAH was compared to a market-leading product. 👉🏿 Link to the press release: https://lnkd.in/dyRqTGn2 🧡 Thank you to everyone involved for the extremely valuable collaboration. Smartare Elektroniksystem Vinnova Formas, ett forskningsråd för hållbar utveckling Energimyndigheten Faisal Zaman Kerstin Jönsson Videsäter Simon Videsäter Tatiana Khudur Thomas Finocchiaro Ina Laura Perkins Seraina Anne Dual Daniel Jonasson Emanuele Perra Karolinska Universitetssjukhuset Karolinska Institutet Kungliga Tekniska högskolan #HeartFailure #TotalArtificialHeart #ArtificialOrgans #Medtech #LifeScience

We are excited to announce that the IonLab at NYU Langone Health has been awarded the S10 grant funding from the NIH to acquire the QPatch II Automated Patch-Clamp. To celebrate this achievement, we will be hosting an OpenHouse event on August 2nd, from 2:00 PM to 5:00 PM, in the Smilow building, room 601A.   The event will include a catered reception sponsored by Sophion Bioscience, where attendees can learn more about our new QPatch II system. This technology enables medium throughput patch clamp screening and offers training that can be completed within a day, making it accessible even to those with minimal electrophysiology background.   🕒 Event Highlights: 2:30 PM: Dr. Soomin C. Song, Operations Manager of the IonLab, will introduce the lab, its services, and the QPatch II. Presentation by our team at Sophion Dr. Pietro Scaduto and Schuyler King on the capabilities and applications of the QPatch II. Tour of the IonLab space to explore potential collaborative projects.   The IonLab, supported by the Department of Pathology and OSR, is dedicated to advancing research in ion channel and transporter function across diverse cell types and organ systems. We believe that the QPatch II will unlock new opportunities for collaboration and advancements in research.   If you are interested in learning more about this system or exploring potential collaborations, we encourage you to attend the Open House. Non-NYU attendees will need to check into the reception desk at either the Main Entrance or the Kimmel Pavilion to enter the superblock. Follow the Yellow Pathway to the Smilow Elevator. Please feel free to reach out with any questions or for further information. We look forward to celebrating this exciting milestone with you! #NYULangone #IonLab #Research #Electrophysiology #ephys #QPatchII #Automatedpatchclamp #Ionchannels

As our first post, we’d like to introduce our project: ‘From Cell Being to Well Being' 🧬 We are a team of 10 students from the FHML Honours Program at Maastricht University 🎓 Our project's focus is Marfan's Syndrome: a genetic condition that impacts connective tissue, causing widespread effects, particularly on the heart, eyes, and skeleton. →  Weakened connective tissue can lead to Thoracic Aortic Aneurysm (TAA), significantly increasing the risk of aortic dissection and heart-related complications 🫀 Our team comes from different bachelor degrees at FHML, being either Biomedical Science, Health Science, or Medicine.  Our goal? To enhance the way Marfan Syndrome is understood, focusing on enhancing scientific communication and creating stronger connections among researchers, health care professionals, and, most importantly, patients 🏥 By breaking down complex scientific concepts into simple insights, we ensure that those affected by Marfan Syndrome are not just informed, but empowered💪🏼 We are committed to creating a platform where knowledge flows freely, and every voice is heard, from the lab bench to the bedside.🥼🔬🧑💼 Daniela Olinic Thijs Hahn Carlynn Felice Luca Hounjet Jodi Orban Radu Dumbraveanu Sophie Ramjoie Luisa Akansu Fleur Post Nika Cindori #MarfanSyndrome #ScientificCommunication #BridgingGaps #FromCellBeingToWellBeing